|

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

RECRUITINGSponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2020-11-01
Est. completion2025-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites
View on ClinicalTrials.gov →

NCT04688190

Summary

This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* clinically significant mitral insufficiency
* patient underwent screening for TMVI
* echocardiography data at baseline (and after TMVI, E2E and surgery)
* follow-up of at least 30 days

Exclusion Criteria:

\- age under 18 years

Conditions2

Heart DiseaseMitral Regurgitation

Locations3 sites

California

1 site
Cedars-Sinai Medical Center, Los Angeles
Los Angeles, California, 90048
Raj Makkar, MD

Massachusetts

1 site
Brigham and Women's Hospital
Boston, Massachusetts, 02115
Tsuyoshi Kaneko, MD

Texas

1 site
Houston Methodist Hospital
Houston, Texas, 77030
Michael Reardon, MD

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.